Ann: CEO presentation to Broker Meets Biotech - Perth, page-45

Hi all, just at the research stage here into FTT and not sure this has been discussed. Cash burn of about 3M this quarter and with 6M in the back at 30/6 seems like they are running it pretty tight leading into results in December. Would you expect small raise (no doubt at a higher price than 4c) in Nov or do you get the impression they are that confident of raising post results? Also might explain the large swings in the SP? I might also be over estimating the cash burn in Q4 as the trail is ending and the patient numbers decrease?